• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    19.14 Down 1.40(6.82%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:20.54
    Open:20.43
    Bid:N/A
    Ask:24.61 x 2300
    1y Target Est:39.60
    Beta:3.513
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:19.08 - 20.53
    52wk Range:16.51 - 40.98
    Volume:240,459
    Avg Vol (3m):373,013
    Market Cap:653.88M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 6.82%653.88M
    GSKDown 2.57%105.78B
    NVSDown 1.77%233.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.41
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.75
    Quarterly EPS Est (Dec-14) :-0.53
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback